Medlumics — No stage disclosed · €926K partial: only one investor's ticket was disclosed

CDTI Innovación announced a €926,000 commitment to Medlumics alongside Asabys Partners (via Sabadell Asabys Health Innovation Investments and Asabys Top Up Fund) and Criteria Bio Ventures. The total round size and stage were not disclosed; Medlumics develops AblaView, an optically guided cardiac ablation catheter system for atrial fibrillation.